Work

An exploratory clinical study investigating the neoadjuvant treatment of HER2-low expressing, stage II-III breast cancer with disitamab vedotin combined with penpulimab (RCVDBCIIR005).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e12620

Authors: Xiaoxiao Liu, Chunying Zhuang, Yuting Song, Ping He, Dan Zheng, Xi Yan, Xiaorong Zhong, Tinglun Tian, Bing Wei, Yu Xin Xie, Jie Chen, Qing Lv, Ting Luo

Institution: West China Hospital of Sichuan University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410814619

Cites:

Cited by: 1

Related to: 10